Stroke research appeal exceeds £100,000
The University is delighted to share the good news that its recent stroke research fundraising appeal has successfully surpassed its target of £100,000.
Gifts to the appeal – launched in December 2020 – will fund a new PhD research post with a focus on haemorrhagic stroke. The new researcher will increase capacity in the Manchester stroke team and support the search for life-saving new treatment.
Professor of Neuroscience, Stuart Allan, leads the team that will welcome the new PhD researcher. He would like to express his gratitude to the hundreds of donors around the world who have helped to find the new post.
Haemorrhagic stroke – otherwise known as brain haemorrhage – is a subtype of stroke. Around half of all patients who experience this type of stroke will die, and this death rate has changed very little in the past thirty years. This is in stark contrast to other diseases that have seen death rates reduce substantially over that time.
There is currently no successful treatment for haemorrhagic stroke, making this is a key area of research focus for the Manchester Stroke Group. Our strengths in Neuroscience research and links with the UK’s largest clinical stroke centre make Manchester particularly well-placed to lead the search for better treatments.
With funds now in place, Professor Allan and team will start making plans to recruit the new researcher. The appeal remains open, and any further donations will be used to fund resources and equipment to support the new researcher’s work.
Visit www.manchester.ac.uk/strokeappeal to make a gift or email supporters@manchester.ac.uk to find out more.